352 related articles for article (PubMed ID: 9405679)
1. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.
Weber RG; Boström J; Wolter M; Baudis M; Collins VP; Reifenberger G; Lichter P
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14719-24. PubMed ID: 9405679
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic alterations in meningiomas.
Galani V; Lampri E; Varouktsi A; Alexiou G; Mitselou A; Kyritsis AP
Clin Neurol Neurosurg; 2017 Jul; 158():119-125. PubMed ID: 28527972
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma.
Ozaki S; Nishizaki T; Ito H; Sasaki K
J Neurooncol; 1999 Jan; 41(2):167-74. PubMed ID: 10222437
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of meningiomas.
Perry A; Gutmann DH; Reifenberger G
J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477
[TBL] [Abstract][Full Text] [Related]
7. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
[TBL] [Abstract][Full Text] [Related]
9. Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoglu H; Atasoy MA; Başaran N; Tel E
Neurol Med Chir (Tokyo); 2003 Jan; 43(1):12-8; discussion 19. PubMed ID: 12568317
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal losses and gains in meningiomas: comparative genomic hybridization (CGH) study of the whole genome.
Maruno M; Yoshimine T; Muhammad AK; Ninomiya H; Hayakawa T
Neurol Res; 1998 Oct; 20(7):612-6. PubMed ID: 9785589
[TBL] [Abstract][Full Text] [Related]
11. Pathological classification and molecular genetics of meningiomas.
Mawrin C; Perry A
J Neurooncol; 2010 Sep; 99(3):379-91. PubMed ID: 20809251
[TBL] [Abstract][Full Text] [Related]
12. Masked hypodiploidy in anaplastic meningiomas by duplication of the original clone found in atypical meningiomas: illustration of the evolution of genetic alterations.
Ely EE; Guzman MA; Calvey LS; Batanian JR
Neuropathology; 2014 Aug; 34(4):353-9. PubMed ID: 24612240
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
14. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
[TBL] [Abstract][Full Text] [Related]
16. Recurrent cytogenetic aberrations in histologically benign, invasive meningiomas of the sphenoid region.
Korshunov A; Cherekaev V; Bekyashev A; Sycheva R
J Neurooncol; 2007 Jan; 81(2):131-7. PubMed ID: 16850103
[TBL] [Abstract][Full Text] [Related]
17. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
18. Novel chromosomal aberrations in a recurrent malignant meningioma.
Pelz AF; Klawunde P; Skalej M; Wieacker P; Kirches E; Schneider T; Mawrin C
Cancer Genet Cytogenet; 2007 Apr; 174(1):48-53. PubMed ID: 17350466
[TBL] [Abstract][Full Text] [Related]
19. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression.
Wrobel G; Roerig P; Kokocinski F; Neben K; Hahn M; Reifenberger G; Lichter P
Int J Cancer; 2005 Mar; 114(2):249-56. PubMed ID: 15540215
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
